ArticleThe Prostate2026

Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.

Himawari Asanuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.